CDK1 and esophageal cancer: The cell cycle assays demonstrated that COR has the ability to alter the expression of cyclin-dependent kinase 1 (CDK1) and cyclin B1, leading to a blockade of the G2/M phase of the cell cycle in esophageal cancer cells (54).